Hims & Hers Health, Inc. faces short-term pressure after missing Novo’s partner list, but lab testing boosts long-term growth ...

Hims & Hers was rated Hold amid margin pressure, Amazon-driven competition, & uncertain catalysts. Learn more about HIMS ...

The Philippines’ Healthcare Information Management Services (HIMS) sector is undergoing major disruption, making talent development crucial for sustained ...

Accessing Testosterone Replacement Therapy shouldn’t make you want to pull your hair out (especially if that’s one of the ...

Hims Weight Loss offers personalized clinical programs with GLP-1 injections, medication management, and ongoing support.

In today's Fantasy Life Newsletter, presented by Hims, lean into chaos in Denver, latest NFL Mock Draft and Underdog DFS ...

In today's Fantasy Life Newsletter, presented by Hims, an epic meltdown in Buffalo, top-36 wide receiver rankings, NFL Mock ...

Since January, leading pharma and biotech companies have pledged $520 billion to expand their manufacturing capacity in the ...

The core challenge for Hims & Hers stems from escalating competition. Amazon Pharmacy has disrupted the market by launching a low-cost offering for weight-loss therapies similar to Wegovy. Market ...

Geopolitical instability across the globe has been a major catalyst for the growth of defense giants, such as Boeing BA and ...

Detailed price information for Keros Therapeutics Inc (KROS-Q) from The Globe and Mail including charting and trades.

Are you looking for investment opportunities in 2026?